GATA5 and hepatocellular carcinoma: Additionally, we revealed that the molecular mechanism of GATA5 inhibition of malignant behaviour of HCC cells occurs through the dysregulation of Wnt/β‐catenin signalling and is accompanied by the suppression of reprogramming gene expression (Figure 8).